Having trouble accessing articles? Reset your cache.

Bioabsorbable everolimus-eluting stent: Phase III data

Data from the first 45 patients receiving Abbott's bioabsorbable everolimus-eluting stent in the second stage of the open-label, international Phase III

Read the full 215 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE